Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07630207 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Vascular Function in Adults With Down Syndrome

Study acronym: VDS
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 5 months later Dec 31, 2026 → May 31, 2027
See other at-risk trials from University of Nevada, Las Vegas

Record History

See every version on ClinicalTrials.gov ↗

  1. Notable Enrollment increased: 24 → 46 participants Show 5 more changesShow less
    • Primary completion pushed from Dec 31, 2026 to May 31, 2027
    • Study completion pushed from Dec 31, 2026 to Dec 31, 2027
    • Eligibility criteria expanded, about 26 words
    • Secondary endpoints: details revised at 5 of 5 entries
    • Study description expanded, about 12 words
  2. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Adults with Down syndrome (Ds) are often thought to have a lower risk of heart and blood vessel disease because they tend to have lower blood pressure (BP) and fewer heart attacks than people without Ds. However, recent research suggests that heart and blood vessel diseases, including stroke, are becoming a more common cause of death in adults with Ds as life expectancy increases. Despite these findings, studies examining heart and blood vessel health in adults with Ds have produced mixed results, making it difficult to determine their true risk and whether preventive strategies are needed. This study will investigate the health of blood vessels in adults with Ds and compare the results with those of adults without Ds. Healthy blood vessels are important because they help deliver blood and oxygen throughout the body. Changes in blood vessel function and stiffness can occur with aging and may increase the risk of heart disease, stroke, kidney disease, and memory problems. The study aims to determine whether adults with Ds experience changes in blood vessel health that may place them at increased cardiovascular risk. Specifically, the study will: (1) Examine how well blood vessels function in adults with Ds; (2) Measure the stiffness of arteries in adults with Ds; (3) Compare two methods used to assess blood vessel function to determine whether a simpler exercise-based test provides results similar to a commonly used standard test. The findings may improve understanding of cardiovascular risk in adults with Ds and help guide future strategies to promote healthy aging in this population.
Trial Details
NCT Number NCT07630207
Lead Sponsor University of Nevada, Las Vegas
Conditions
(from sponsor)
Down Syndrome (Trisomy 21)
Related terms Down Syndrome
Enrollment 46 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov